Recent study shows traditional Chinese medicine derived therapy to be effective against brain tumors in mice, pening promising line of inquiry for glioblastoma treatment.
Scientists extended the lifespan of mice with malignant brain tumors by using indirubin, according to research published in Cell Reports Medicine on April 14. In order to move the possible pharmaceutical strategy closer to human participant clinical trials. They also evaluated a novel formulation that was simpler to give.
The discovery of a derivative of a naturally occurring substance will influence future research on humans. Indirubin offers a novel method for treating glioblastoma in mice.
Researchers have demonstrated the effectiveness of a medicine derived from the natural substance indirubin in treating malignant brain tumors in mice. The study moves the medication closer to human clinical trials. And involves collaboration between organisations including Brown University and Harvard Medical School. The treatment for glioblastoma, known as 6′-bromoindirubin acetoxime (BiA), reduced tumour development and increased survival rates.
A promising line of inquiry for the treatment of glioblastoma has been opened up by a recent study. The study demonstrates the effectiveness of a therapy derived from a natural substance used in traditional Chinese medicine against malignant brain tumours in mice.
Indirubin boosted the lifespan of mice with malignant brain tumors in a study published in Cell Reports Medicine on April 14. In order to move the possible pharmaceutical strategy closer to human participant clinical trials, they also evaluated a novel formulation that was simpler to give.
Sean Lawler, the principal author and a researcher at the Legorreta Cancer Center of Brown University, said, “The remarkable thing about this treatment is that it targets a lot of significant markers of the disease.” That’s appealing since this sort of cancer consistently evades specific modes of attack. So perhaps we will have better success if we employ several different attack strategies simultaneously.
According to the researchers, indigo plants naturally contain indirubin. Which is also a component of the traditional Chinese medicine Dang Gui Long Hui Wan. It has been used to treat chronic myelogenous leukaemia. Via a variety of processes, indirubin derivatives have demonstrated potential for the treatment of cancer.
Indirubin inhibited the growth of glioblastoma tumours in rats, according to research published ten years ago by Lawler and colleagues. He added that the researchers were unable to provide an explanation for this. The modified medicine was challenging to handle. Making it hard for scientists to determine appropriate dosages or transport it to the tumor.
In addition to slowing tumour cell growth and proliferation (confirming the findings of earlier research), BiA significantly enhanced survival by impacting key immunotherapeutic targets.
For the treatment of brain tumours, Lawler’s lab has developed therapeutic strategies. Animal tests show that the drug could boost clinical immunotherapy by altering the immune system. Lawler said.
Visit CxO Global FORUM or CxO News Live for all the latest updates.
